SIMPLY BETTER BRANDS CORP (SBBC.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:SBBC - CA82888R1055 - Common Stock
0.86 CAD
-0.04 (-4.44%)
Taking everything into account, SBBC scores 3 out of 10 in our fundamental rating. SBBC was compared to 32 industry peers in the Pharmaceuticals industry. SBBC has a bad profitability rating. Also its financial health evaluation is rather negative. SBBC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SBBC has reported negative net income.
SBBC had a positive operating cash flow in the past year.
In the past 5 years SBBC always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: SBBC reported negative operating cash flow in multiple years.
1.2 Ratios
SBBC has a better Return On Assets (-1.47%) than 61.76% of its industry peers.
Looking at the Return On Equity, with a value of -22.83%, SBBC is in line with its industry, outperforming 47.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.47% | ||
| ROE | -22.83% | ||
| ROIC | N/A |
ROA(3y)-53.1%
ROA(5y)-47.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SBBC has a Gross Margin (29.78%) which is comparable to the rest of the industry.
SBBC's Gross Margin has declined in the last couple of years.
SBBC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.78% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.17%
GM growth 5YN/A
2. Health
2.1 Basic Checks
SBBC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SBBC has more shares outstanding
Compared to 5 years ago, SBBC has more shares outstanding
The debt/assets ratio for SBBC has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -0.48, we must say that SBBC is in the distress zone and has some risk of bankruptcy.
SBBC has a Altman-Z score of -0.48. This is comparable to the rest of the industry: SBBC outperforms 58.82% of its industry peers.
SBBC has a debt to FCF ratio of 6.61. This is a slightly negative value and a sign of low solvency as SBBC would need 6.61 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 6.61, SBBC is doing good in the industry, outperforming 79.41% of the companies in the same industry.
SBBC has a Debt/Equity ratio of 2.69. This is a high value indicating a heavy dependency on external financing.
SBBC's Debt to Equity ratio of 2.69 is on the low side compared to the rest of the industry. SBBC is outperformed by 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.69 | ||
| Debt/FCF | 6.61 | ||
| Altman-Z | -0.48 |
ROIC/WACCN/A
WACC7.68%
2.3 Liquidity
SBBC has a Current Ratio of 0.90. This is a bad value and indicates that SBBC is not financially healthy enough and could expect problems in meeting its short term obligations.
SBBC has a Current ratio of 0.90. This is amonst the worse of the industry: SBBC underperforms 82.35% of its industry peers.
SBBC has a Quick Ratio of 0.90. This is a bad value and indicates that SBBC is not financially healthy enough and could expect problems in meeting its short term obligations.
SBBC has a worse Quick ratio (0.74) than 73.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 98.61% over the past year.
Looking at the last year, SBBC shows a very negative growth in Revenue. The Revenue has decreased by -42.52% in the last year.
The Revenue has been growing by 42.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.93%
Revenue 1Y (TTM)-42.52%
Revenue growth 3Y42.58%
Revenue growth 5YN/A
Sales Q2Q%3.75%
3.2 Future
SBBC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.10% yearly.
The Revenue is expected to grow by 35.80% on average over the next years. This is a very strong growth
EPS Next Y0%
EPS Next 2Y29.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year41.19%
Revenue Next 2Y35.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SBBC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SBBC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SBBC indicates a somewhat cheap valuation: SBBC is cheaper than 64.71% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 58.09 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SBBC's earnings are expected to grow with 29.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.1%
EPS Next 3YN/A
5. Dividend
5.1 Amount
SBBC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:SBBC (10/3/2025, 7:00:00 PM)
0.86
-0.04 (-4.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap92.54M
Revenue(TTM)45.90M
Net Income(TTM)-377.00K
Analysts84
Price Target2.3 (167.44%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-200%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.44 | ||
| P/FCF | 58.09 | ||
| P/OCF | 57.09 | ||
| P/B | 39.98 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.01
FCFY1.72%
OCF(TTM)0.02
OCFY1.75%
SpS0.6
BVpS0.02
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.47% | ||
| ROE | -22.83% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.78% | ||
| FCFM | 2.48% |
ROA(3y)-53.1%
ROA(5y)-47.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.17%
GM growth 5YN/A
F-Score5
Asset Turnover1.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.69 | ||
| Debt/FCF | 6.61 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.3% | ||
| Cap/Sales | 0.04% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | -0.48 |
F-Score5
WACC7.68%
ROIC/WACCN/A
Cap/Depr(3y)2.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.18%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.93%
EPS Next Y0%
EPS Next 2Y29.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.52%
Revenue growth 3Y42.58%
Revenue growth 5YN/A
Sales Q2Q%3.75%
Revenue Next Year41.19%
Revenue Next 2Y35.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year271.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y133.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.46%
OCF growth 3YN/A
OCF growth 5YN/A
SIMPLY BETTER BRANDS CORP / SBBC.CA FAQ
What is the ChartMill fundamental rating of SIMPLY BETTER BRANDS CORP (SBBC.CA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SBBC.CA.
What is the valuation status for SBBC stock?
ChartMill assigns a valuation rating of 2 / 10 to SIMPLY BETTER BRANDS CORP (SBBC.CA). This can be considered as Overvalued.
Can you provide the profitability details for SIMPLY BETTER BRANDS CORP?
SIMPLY BETTER BRANDS CORP (SBBC.CA) has a profitability rating of 2 / 10.
What is the expected EPS growth for SIMPLY BETTER BRANDS CORP (SBBC.CA) stock?
The Earnings per Share (EPS) of SIMPLY BETTER BRANDS CORP (SBBC.CA) is expected to decline by 0% in the next year.
How sustainable is the dividend of SIMPLY BETTER BRANDS CORP (SBBC.CA) stock?
The dividend rating of SIMPLY BETTER BRANDS CORP (SBBC.CA) is 0 / 10 and the dividend payout ratio is 0%.